194 related articles for article (PubMed ID: 9540194)
1. [Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities].
Lampel A; Thüroff JW
Urologe A; 1998 Jan; 37(1):93-101. PubMed ID: 9540194
[No Abstract] [Full Text] [Related]
2. [Interdisciplinary strategies for the treatment of bladder cancer].
Bauer W; Lamche M; Schramek P
Wien Med Wochenschr; 2007; 157(7-8):153-6. PubMed ID: 17492411
[TBL] [Abstract][Full Text] [Related]
3. New trends for optimal management of bladder tumors.
Pfister C
J Urol; 2001 Jan; 165(1):65-6. PubMed ID: 11125365
[No Abstract] [Full Text] [Related]
4. [Treatment of locally advanced carcinoma of the urinary bladder with preoperative radiotherapy and radical cystectomy versus radical cystectomy alone].
Smith JA; Crawfort ED; Paradelo JC; Blumenstein B; Herschman BR; Grossman HB; Christie DW
Urologe A; 1998 Sep; 37(5):532-3. PubMed ID: 9796037
[No Abstract] [Full Text] [Related]
5. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
Montie JE
J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
[No Abstract] [Full Text] [Related]
6. The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
deVere White RW; Katz MH; Steinberg GD
J Urol; 2009 May; 181(5):1994-7. PubMed ID: 19286209
[No Abstract] [Full Text] [Related]
7. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
[No Abstract] [Full Text] [Related]
9. Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
Sternberg CN
Ann Oncol; 2002; 13 Suppl 4():273-9. PubMed ID: 12401701
[No Abstract] [Full Text] [Related]
10. T1 and T2 bladder cancer: selecting optimal therapy.
Soloway MS
Eur Urol; 1998; 33 Suppl 4():16-7. PubMed ID: 9615202
[No Abstract] [Full Text] [Related]
11. [Current developments in the diagnostics and therapy of bladder carcinoma].
Kamradt J; Ohlmann CH; Stöckle M
Urologe A; 2011 Sep; 50 Suppl 1():179-83. PubMed ID: 21863408
[TBL] [Abstract][Full Text] [Related]
12. Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy.
Zietman AL
Front Radiat Ther Oncol; 2002; 36():131-46. PubMed ID: 11842743
[No Abstract] [Full Text] [Related]
13. Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy.
Granfors T; Duchek M; Tomic R; Roos G; Ljungberg B
Scand J Urol Nephrol; 1996 Aug; 30(4):281-5. PubMed ID: 8908649
[TBL] [Abstract][Full Text] [Related]
14. [Therapy and follow-up of bladder cancer].
Meyer D; Schmid HP; Engeler DS
Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413
[TBL] [Abstract][Full Text] [Related]
15. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
16. Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
Amini E; Ahmadi N; Clifford TG; Hugen CM; Bazargani ST; Cai J; Miranda G; Sherrod AE; Daneshmand S; Djaladat H
Int Urol Nephrol; 2019 Mar; 51(3):435-441. PubMed ID: 30706249
[TBL] [Abstract][Full Text] [Related]
17. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.
Scher HI
J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114
[No Abstract] [Full Text] [Related]
18. Invasive bladder cancer--where do we go from here?
Waters WB
J Urol; 1996 Jun; 155(6):1910-1. PubMed ID: 8618285
[No Abstract] [Full Text] [Related]
19. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
Martínez Portillo FJ; Alken P
Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
[No Abstract] [Full Text] [Related]
20. T1G3: What to do?
Mandressi A
Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
